FDA Approved: NOXAFIL — Supplemental Application (Merck Sharp & Dohme LLC)

View source ↗

Summary

The FDA approved a supplemental application for NOXAFIL (posaconazole) from Merck Sharp & Dohme LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Invasive Aspergillosis
• Invasive Candidiasis
• Oropharyngeal Candidiasis

Drugs mentioned

• NOXAFIL (POSACONAZOLE)

Snippet

SUPPL AP for NOXAFIL (POSACONAZOLE)